Research linking two decades of data on Australian women with outcomes for their children will provide an unparalleled insight into child health and development.
University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.
The University of Queensland congratulates ResApp Health Limited (ASX:RAP) following the company’s success at the global Talent Unleashed Awards in Sydney last night.
A University of Queensland researcher who is developing new imaging technology to diagnose and treat schizophrenia has received a $200,000 project boost.